Absence Seizure clinical trials

Explore recruiting absence seizure clinical trials.

Recruiting absence seizure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Absence Seizure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Study on the investigational drug SAN711, placebo-controlled, administered to healthy adults and elderly subjects at multiple ascending oral doses to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics of SAN711 and its interaction with food

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Spain, Slovakia, Romania, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Absence Seizure trials by city

Absence Seizure in Toronto Absence Seizure in Vancouver Absence Seizure in Montreal Absence Seizure in Calgary Absence Seizure in Edmonton Absence Seizure in Ottawa Absence Seizure in Winnipeg Absence Seizure in Quebec City Absence Seizure in Hamilton Absence Seizure in Kitchener Absence Seizure in London Absence Seizure in Halifax Absence Seizure in New York Absence Seizure in Los Angeles Absence Seizure in Chicago Absence Seizure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease